Key result
Losartan blunts Angiotensin II-induced contraction in isolated human coronary arteries.
Why the study?
Does losartan inhibit angiotensin II-induced contraction in isolated human coronary arteries?
Does losartan inhibit angiotensin II-induced contraction in isolated human coronary arteries?
Answers are grounded in this paper and cite their sources.
This in vitro study demonstrates that angiotensin II induces vasoconstriction in human coronary arteries, which is effectively antagonized by the AT1 receptor blocker losartan.
The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The development of specific Ang II-receptor antagonists has made it possible to delineate more carefully the receptor mechanisms involved. The objective of this study was twofold: to investigate the effect of Ang II on human coronary arteries and to study the effects of angiotensin II type 1 receptor blockade with losartan. The setting was contractile experiments with ring segments of coronary arteries. We observed that Ang II is a vasoconstrictor of human coronary arteries, with a pEC50 value of 9.26 +/- 0.22 and Emax of 68.7 +/- 9.61% of potassium-induced contraction. Losartan (10-100 nM) shifted the concentration-response curve of Ang II to the right, with pEC50 values of 7.64 +/- 0.10 and 7.00 +/- 0.15, respectively (p = 0.001), demonstrating the antagonistic properties of losartan. We also noted a decreased maximal response to Ang II after incubation of losartan, with Emax of 51.1 +/- 7.08% and 41.9 +/- 4.70% (p = 0.05), respectively. In conclusion, this is the first report describing the contractile effect of Ang II and the antagonizing effects of losartan in isolated human coronary arteries.
No takes yet. Share an insight, caveat, or question.
Holmgren et al. (1998) studied this question. Losartan vs. Angiotensin II alone was evaluated on Contractile effect of Angiotensin II (pEC50 and Emax) (p=0.001). Losartan antagonized Angiotensin II-induced contraction in isolated human coronary arteries, shifting the pEC50 from 9.26 to 7.00 and decreasing Emax.
Synapse has enriched 10 related papers. Consider them for comparative context: